TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 14 filers reported holding TRILLIUM THERAPEUTICS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $100,092,000 | +81.0% | 5,700,000 | 0.0% | 1.57% | +63.4% |
Q2 2021 | $55,290,000 | -9.7% | 5,700,000 | 0.0% | 0.96% | -9.0% |
Q1 2021 | $61,218,000 | -28.2% | 5,700,000 | -1.7% | 1.06% | -28.0% |
Q4 2020 | $85,318,000 | +9.2% | 5,800,000 | +5.5% | 1.47% | +32.3% |
Q3 2020 | $78,155,000 | +103.4% | 5,500,000 | +15.8% | 1.11% | +46.1% |
Q2 2020 | $38,428,000 | +92.2% | 4,750,000 | -4.0% | 0.76% | +12.6% |
Q1 2020 | $19,998,000 | +1329.4% | 4,950,000 | +2076.8% | 0.68% | +277.1% |
Q1 2017 | $1,399,000 | +8.9% | 227,399 | 0.0% | 0.18% | -31.2% |
Q4 2016 | $1,285,000 | -72.5% | 227,399 | -28.0% | 0.26% | -68.3% |
Q3 2016 | $4,671,000 | +127.4% | 316,020 | +38.2% | 0.82% | +79.8% |
Q2 2016 | $2,054,000 | -2.9% | 228,697 | 0.0% | 0.46% | -38.2% |
Q1 2016 | $2,115,000 | -33.9% | 228,697 | -9.9% | 0.74% | -33.0% |
Q4 2015 | $3,199,000 | -4.5% | 253,697 | -0.5% | 1.10% | +26.5% |
Q3 2015 | $3,351,000 | +62.7% | 255,097 | +170.2% | 0.87% | +53.6% |
Q2 2015 | $2,060,000 | -36.3% | 94,400 | -41.3% | 0.57% | -54.3% |
Q1 2015 | $3,234,000 | – | 160,697 | – | 1.24% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NEA Management Company, LLC | 2,100,000 | $646,000 | 0.05% |
Matrix Capital Management Company, LP | 2,288,560 | $704,000 | 0.02% |
Tekla Capital Management LLC | 446,099 | $137,000 | 0.01% |
Realta Investment Advisors | 26,000 | $7,000 | 0.00% |
Virtu Financial LLC | 34,991 | $11,000 | 0.00% |
Baker Brothers Advisors | 505,262 | $155,000 | 0.00% |
BOOTHBAY FUND MANAGEMENT, LLC | 20,044 | $6,000 | 0.00% |
MORGAN STANLEY | 1,160,098 | $356,000 | 0.00% |
BANK OF MONTREAL /CAN/ | 18,333 | $6,000 | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 102,725 | $31,000 | 0.00% |